本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PMV Pharmaceuticals

1.40
-0.0400-2.78%
盤後1.430.0300+2.14%19:31 EDT
成交量:53.87萬
成交額:78.73萬
市值:1.06億
市盈率:-0.99
高:1.51
開:1.45
低:1.40
收:1.44
52周最高:1.88
52周最低:1.02
股本:7,551.31萬
流通股本:6,838.37萬
量比:0.80
換手率:0.79%
股息:- -
股息率:- -
每股收益(TTM):-1.4131
每股收益(LYR):-1.4800
淨資產收益率:-70.93%
總資產收益率:-42.39%
市淨率:1.48
市盈率(LYR):-0.95

資料載入中...

2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/23

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/05

重要事件披露

Form 8-K - Current report
2023/11/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/13

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/08/24

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

重要事件披露

Form 8-K - Current report
2023/06/09

重要事件披露

Form 8-K - Current report
2023/05/19

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals